Titrating a dose: why you climb, and how to know when to stop
Every approved incretin protocol climbs in steps instead of starting at the target dose. Here is the reasoning behind that, and the one mistake that breaks a schedule.
Practical
The procedural parts do not vary by compound, so they live here rather than being repeated on every profile. Technique, not protocol — how to mix a vial without ruining it is a different question from what to put in it.
Every approved incretin protocol climbs in steps instead of starting at the target dose. Here is the reasoning behind that, and the one mistake that breaks a schedule.
Two different arguments both get called cycling, and only one of them is about receptors. Pulling them apart tells you which compounds it actually applies to.
Temperature, paperwork, and the fact that legal status changes when you cross a line on a map. Two of those have practical answers.
Where the numbers on a compound page come from, what a range is telling you, and the unit slips that turn a protocol into a tenfold error.
Mixing a freeze-dried vial without contaminating it or destroying what is inside. The technique is the same for every compound; only the numbers change.
Dry powder and mixed solution have completely different shelf lives. The clock that matters starts when you add water.
Where subcutaneous injections go, and why using the same spot repeatedly is the most common avoidable problem.
Research chemicals carry no manufacturing standard. What a certificate of analysis actually tells you, and what a useless one looks like.
Next